The aim of this work was to develop a cream formulation with potential antioxidant properties. Herein, a freeze-dried extract of Ligusticum mutellina was used as a source of active compounds. The proposed qualitative composition of the cream was characterized by a good polyphenolic compounds release profile. Of note, the highest R 2 adj values were obtained for the Korsmeyer-Peppas and Higuchi models (0.9159 and 0.9226, respectively). These results indicate that a freeze-dried extract of L. mutellina, due to its retained high phenolic acids content, could become a key component in antioxidant creams.
INTRODUCTION
In a majority of cosmetic creams, active plant substances are common ingredients that are responsible for several beneficial, multidirectional properties, among others, antioxidant, antibacterial, antifungal, anti-inflammatory or astringent activity [14, 18, [21] [22] [23] [24] . This action is conditioned by the chemical composition of the plant substances used in the cosmetic. The most frequently listed group of natural protective compounds are phenolic acids. These occur in plants predominantly in a linked form as esters and glycosides, or as more complex lignans and hydrolysable tannins. Compounds derived from hydroxycinnamates often form ester linkage with carboxylic acids or glucose, and derivatives of hydroxybenzoic acids are usually present as glycosides [7] . Breinholt [3] described combinations of phenolic acids with the flavonoids. fatty acids and sterols present in the plant cells. Phenolic acids are biogenetically formed in plants from shikimic acid via the phenylpropanoid pathway, as well as through the degradation of lignin and cell wall polymers in vascular plants [4, 6] .
The presented work is a continuation of earlier research on the phytochemical composition and activity of extracts from the L. mutellina herb, which showed interesting biological properties [19, 20] .
The aim of this work was to develop a cream formulation with potential antioxidant properties containing a lyophilized extract of L. mutellina as an active ingredient.
MATERIAL AND METHODS
The herb of L. mutellina was collected in the botanical garden of the Department of Pharmacognosy, Medical Plant Unit, Medical University of Lublin, in September 2010. The herb was dried in the shade, pulverized and sieved (0.5 mm sieve).
Preparation of the extract from L. purpurea herb
In this preparation, 300 mL of distilled water was added to the plant material (100 g) and the extract was produced via the heating basket under reflux for 2h. Subsequently, this was concentrated to a volume of 50 mL under reduced pressure on a rotary evaporator and subjected to freezedrying (Freeze Dryer, Christ Alpha 2-4 LD, Germany).
Preparation of cream containing the lyophilized extract
85.0 g of cholesterol ointment was mixed with 5.0 g of lyophilisate, 5.0 g of Miglyol 812 and 5.0 g of cis-oleic acid. The ingredients were transferred into a container and were stirred in the automatic mixer (Unguator 2100, Gako, Germany) for 2 minutes at a speed of stirrer 5. The choice of a cholesterol ointment as a cream base was justified by the nature of the active substances present in the extract of L. mutellina. Due to the hydrophilic properties of the dominant component, chlorogenic acid (log P = 0.6), it was not possible to utilize bases containing a large amount of water (hydrogels, o/w emulsion), as these would not enable a release and penetration of active substances into the stratum corneum of the skin. What is more, an emulsion base was rejected during preliminary tests due to its limited stability. In our work, Oleic acid and Miglyol were added to improve the lubricating properties of the ointment. Doing this also
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Current Issues in Pharmacy and Medical Sciences PROOF achieved the effect of promoting absorption (oleic acid). While some antioxidants are usually included within such formulations so as to inhibit the degradation of the active substances, in this study, this was not done, as their addition would cause overestimation of the results obtained using F-C reagent.
Permeation studies
The assessment of pharmaceutical availability of ointment polyphenols was performed in a chamber Enhancer cell -a six-position apparatus with a paddle attachment. The agitator speed was 50 revolutions/min, the chamber extraction surface was 400 mm 2 and measurements were carried out at 40±0.5°C (the temperature of the acceptor fluid). In doing this, 1 g of ointment was weighed and placed in the cell, then the ointment was covered with a Cuprophan membrane (previously exposed to distilled water for 24h). The cells were then placed in a beaker containing 100 mL of the acceptor fluid (1.6% SLS -sodium lauryl sulfate).
Determination of the sum of phenolic compounds in the liquid acceptor
For the sum of phenolic compounds determination, 1 mL of acceptor solution was taken at appropriate time intervals. In so-doing, 1 mL of acceptor solution was mixed with 0.5 mL of Folin-Ciocaltou reagent (diluted 10 × with distilled water). After 5 minutes, 0.5 mL of sodium bicarbonate was added and the mixture was left for 30 minutes in the dark. Absorbance was measured in the presence of water at λ = 735 nm.
To generate the calibration curve, 2 mg of chlorogenic acid was exactly weighed and dissolved in 2 mL of methanol (basic solution). The prepared dilutions were in a range of 0.86-4.23 mg/mL. The concentration of phenolic compounds in the liquid acceptor was calculated by using the equation: Abs = 0.07840 × conc -0.04815.
Statistical analysis
The obtained results were used to determine the most appropriate kinetic model describing the process of release. For this purpose a free app for MS Excel -DDSolver was used [27] .
RESULTS AND DISCUSSION
Following 24h, approx. 12% of the contained polyphenols were released as chlorogenic acid. Table 1 and Figure 1 present the release kinetics of active compounds from ointment. Moreover, the results of matching the kinetics of release to the individual models are shown in Table 1 . The best match was obtained by way of the Higuchi model (highest R 2 adj), which either describes the release from semisolid formulations or it describes formulations with a modified release [5] . Initially, the Higuchi model referred to the release of planar systems [9] but was extended to a system with different shapes and pore types [8] . This model is based on the assumption that an initial concentration in the matrix is much higher than its solubility, diffusion occurs only in one direction, the particles of the substance are much smaller than the thickness of the system, soaking of the system and its dissolution practically do not occur, the diffusivity of the system is unchanging and the condition of immersion in the environment of acceptor is kept. The Higuchi model relating to the semisolid formulations is described by the equation:
where, Q is the amount of substance released at time t per unit area A, C is the initial concentration of the substance, C s is the solubility of the substance in the base, and D is the diffusivity of the molecules (diffusion coefficient) in the base. This relationship is valid for the entire release time, until exhaustion of reservoir analyte.
The simplified Higuchi model [9] is described by the equation:
where, K H is a Higuchi constant decomposition [1] .
Compounds of plant origin with antioxidative properties possess the ability to inhibit certain enzymes, "capture" the singlet oxygen, degrade peroxides and also to support other antioxidants [12] . Chlorogenic acid is among the more potent herbal antioxidants. Structurally, this is an ester of caffeic and quinic acid, and it is also an antiviral and an antibacterial agent [22] that is active against gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis) and Gram-negative bacteria (Escherichia coli) [28] . In addition, it acts as an anti-allergic compound [10] , modulates the activity of cytochrome P450 [26] , exhibits antiviral properties against HIV [13] and demonstrates anti-tumor effects [25] . Furthermore, chlorogenic acid has no inhibitory effect PROOF cell proliferation. This differentiates chlorogenic acid from the other broad spectrum MMP inhibitors such as batimastat (BB-94) [15, 17] . Kono et al. [11] reported that the antioxidant properties of chlorogenic acid are linked to the catechol structure of the phenyl ring. The double bond adjacent to the catechol unit also provides a place holder for the free radicals. Chlorogenic acid also strongly inhibits zinc-dependent metalloproteinases of the intercellular matrix. Metalloproteinases (MMPs) are involved in the cleavage of surface receptors and the release of apoptotic ligands, as well as in the activation and deactivation of chemokines and cytokines. Moreover, metalloproteinases play a very important role in cell reproduction, migration, differentiation, angiogenesis and apoptosis. Of the metalloproteinases, MMP-9 is involved in the degradation of type IV collagen, a major component of the extracellular matrix [2, 16] . Chlorogenic acid has selective, dose-dependent activity towards MMP-9. Herein, the IC50 is in the range of 30-50 nM.
CONCLUSION
L. mutellina extract has a high content of polyphenols, and in our work, a freeze-dried extract was used to prepare a skin care cream composition having potential antioxidant properties. The proposed qualitative composition of the cream was characterized by it having a good polyphenolic compounds release profile. Indeed, all release profiles showed a high rate of R 2 adj. The highest R 2 adj value, however, was obtained via the Korsmeyer-Peppas and Higuchi models (0.9159 and 0.9226, respectively). These results indicate that a freeze-dried extract of L. mutellina retains a high content of phenolic acids, and that it may be utilized within certain antioxidant cream formulations.
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